“…To determine whether HIV diversity impacts the ARCHITECT HIV Combo Ag/Ab (HIV Combo) or RealTime HIV-1 (RT) assays, a set of N = 199 HIV clinical specimens from Cameroon, Senegal, Saudi Arabia, and Thailand were sequenced and tested in both assays. …”
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου

“…We evaluated the use of DBS whole blood samples in the modified Abbott ARCHITECT anti-HCV assay, comparing assay performance against the standard assay run using DBS and venous plasma samples. 144 HCV positive and 104 HCV negative matched venous plasma and whole blood specimens were selected from a retrospective study with convenience sampling in Cameroon. …”
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου

“…Samples were screened for HDV antibodies on the Abbott ARCHITECT instrument and for HDV RNA on the Abbott m2000 instrument by research assays. …”
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου

“…All specimens were screened for HCV using the Abbott RealTime HCV viral load assay and positive specimens with remaining volume were also screened for HPgV‐2 antibodies on the Abbott ARCHITECT instrument, followed by molecular characterization. …”
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου